Clinical Trial Update: Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying the efficacy of topical ruxolitinib 1.5% cream in adults with discoid lupus erythematosus; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Discoid Lupus Erythematosus

Drugs mentioned

• Ruxolitinib 1.5% Cream (ruxolitinib)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Discoid Lupus Erythematosus | Phase 2 | Status: RECRUITING